Previous studies have shown that the lymphoblastic leukemia CEM cell line is resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis because of a low expression of caspase-8. Bcl-2 inhibitors, BH3I-2 and HA14-1, are small cell-permeable nonpeptide compounds, are able to induce apoptosis by mediating cytochrome c release, and also lead to dissipation of the mitochondrial membrane potential (⌬⌿m). This study aimed to use the Bcl-2 inhibitors to sensitize CEM cells to TRAIL-induced apoptosis by switching on the mitochondrial apoptotic pathway. We found that a low dose of BH3I-2 or HA14-1, which did not induce cytochrome c release, greatly sensitized CEM cells to TRAIL-induced apoptosis. In a similar manner to the classical uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP), both BH3I-2 and HA14-1 induced a reduction in ⌬⌿m, a generation of reactive oxygen species (ROS), an increased mitochondrial respiration, and a decreased ATP synthesis. This uncoupling function of the Bcl-2 inhibitors was responsible for the synergy with TRAIL-induced apoptosis. CCCP per se did not induce apoptosis but again sensitized CEM cells to TRAILinduced apoptosis by uncoupling mitochondrial respiration. The uncoupling effect facilitated TRAIL-induced Bax conformational change and cytochrome c release from mitochondria. Inhibition of caspases failed to block TRAIL-mediated cell death when mitochondrial respiration was uncoupled. We observed that BH3I-2, HA14-1, or CCCP can overcome resistance to TRAIL-induced apoptosis in TRAIL-resistant cell lines, such as CEM, HL-60, and U937. Our results suggest that the uncoupling of mitochondrial respiration can sensitize leukemic cells to TRAIL-induced apoptosis. However, caspase activation per se does not represent an irreversible point of commitment to TRAIL-induced cell death when mitochondrial respiration is uncoupled.
INTRODUCTION
Apoptosis initiated by TRAIL is largely dependent on the cellextrinsic signaling pathway, which involves death receptor engagement, the death-inducing signaling complex formation, proteolytic activation of the apical caspases, caspase-8 and -10, and consequently, activation of effector caspases such as caspase-3, -6, and -7 (1, 2) . In certain types of cells, effector caspase activation requires amplification of death-inducing signaling complex signals by engagement of the cell-intrinsic pathway. A critical step in the cell-intrinsic pathway is the activation of Bax, leading to dissipation of the mitochondrial transmembrane potential (⌬⌿m) and cytochrome c release into the cytosol. This facilitates assembly of the Apaf-1 apoptosome with recruitment and activation of caspase-9 and subsequently the effector caspases (3) . Multidomain proapoptotic members of the Bcl-2 family, such as Bax and Bak, are counterbalanced by the antiapoptotic family members Bcl-2 or Bcl-XL (4). BH3-only proteins, such as Bid, interact with proapoptotic Bcl-2 family members to augment their activity. Once cleaved by caspase-8 during treatment with TRAIL, Bid translocates to the mitochondria and activates Bax, thus providing a mechanism for cross-talk between the extrinsic and intrinsic apoptotic pathways (5, 6) .
The requirement for Bax activation in TRAIL-induced apoptosis is cell type dependent (7) (8) (9) (10) . Early events triggered by TRAIL, such as death-inducing signaling complex formation, caspase-8 activation, and Bid cleavage were not dependent on Bax; however, mitochondrial depolarization, cytochrome c release, and activation of caspase-9 were prevented in Bax-deficient cells (9, 11) . Thus, in these cells, the intrinsic pathway was required for TRAIL-mediated apoptosis, with Bax being essential for induction of the mitochondrial events.
BH3I-2Ј and HA14-1 are small nonpeptidic organic compounds that interact with the surface pocket of Bcl-2 and can be used as cell-permeable agents to affect Bcl-2-regulated apoptotic pathways and are called inhibitors of Bcl-2 or BH3-mimetic compounds (12, 13) . These small compounds not only induce cytochrome c release from mitochondria but also dissipate ⌬⌿m (12) (13) (14) .
The mitochondria of healthy cells maintain an electrochemical gradient across the mitochondrial inner membrane (MIM) that is created by pumping protons from the matrix to the inter-membrane space of these organelles in conjugation with electron transport through the respiratory chain. The proton gradient and membrane potential are the proton-motive force that is used to drive ATP synthesis. Coupling of electron transport through the respiratory chain and ATP generation can be disrupted by some acidic aromatic substances such as carbonyl cyanide m-chlorophenylhydrazone (CCCP) and 2,4-dinitrophenol. These so-called uncouplers of oxidative phosphorylation carry protons across the inner mitochondrial membrane. This specific attack of oxidative phosphorylation leads to a reduction of ⌬⌿m, to the cessation of ATP generation in the mitochondrion, and to the collapse of the pH gradient by shuttling protons back across the membrane (15) .
Alteration in mitochondrial function can change the sensitivity of tumor cells to apoptosis mediated by death receptors. Increase in mitochondrial respiration sensitizes leukemic cells to tumor necrosis factor-mediated apoptosis (16) . Depletion in mitochondrial DNA renders tumor cells resistant to apoptosis induced by TRAIL (17) . The uncoupler CCCP can enhance the Fas death signal, although CCCP alone does not have an apoptotic effect (18) . However, the precise mechanism by which the mitochondrial function contributes to death receptor-mediated apoptosis is still unclear.
In this study, we used BH3I-2Ј or HA14-1 as a sensitizer for overcoming the resistance of leukemic cells to TRAIL-induced apoptosis. It was found that both BH3I-2Ј and HA14-1 showed an uncoupling effect on the oxidative phosphorylation when they were used at the concentrations that could not induce cytochrome c release and apoptosis. CCCP, which does not induce apoptosis, also showed a large synergistic effect on TRAIL-induced apoptosis in leukemic cells. Our data showed that the synergistic effect of uncoupling agents on TRAIL-induced apoptosis is via the intrinsic apoptotic pathway M BH3I-2Ј, 10 M HA14-1, or 10 M CCCP for up to 24 h. For the cotreatment, cells were pretreated with 30 M BH3I-2Ј, 10 M HA14-1, or 10 M CCCP for 1 h and then treated together with 500 ng/ml TRAIL for up to 24 h.
Apoptosis Assay by Flow Cytometry. DNA content was measured by flow cytometry. Cells were permeabilized with 70% ethanol and stained with 100 g/ml PI. PI fluorescence of nuclei was measured by a FACScan flow cytometer (Becton Dickinson, Cambridge, United Kingdom). Data analysis was carried out on cells gated on an FL2-Area channel versus FL2-Width channel display to exclude cell debris and clumped cells. DNA content distribution (PI fluorescence) was analyzed on the FL2-Area histogram, and cells with a DNA content less than G 0 /G 1 (hypodiploid) were defined as apoptotic cells (7) .
Soft Agar Assay for Colony Formation. Two percent of gum agar was melted in a microwave and cooled to 50 -60°C in a water bath. Eagle's Minimum Essential Medium (EMEM) and 20% FCS were prewarmed to 40°C in water bath. Agar was mixed with medium and FCS to give 0.5% agar and 10% FCS. Two ml of 0.5% agar were added to each 35-mm Petri dish and allowed to set. The top agar was prepared with 2% agar, EMEM, and FCS to give 0.3% agar and 10% FCS. Agar (1.8 ml of 0.3%) was mixed with 0.2 ml of CEM cell suspension (containing 2 ϫ 10 4 cells) by vortexing the contents vigorously until the cells were evenly suspended. The cell-containing mixture was plated in a 2-ml volume on the top agar. The dish was overlaid with 1 ml of EMEM containing supplements and with or without 30 M BH3I-2Ј or 10 M HA14-1. Cells were incubated for 1 week at 37°C in 5% CO 2 before counting colonies (19) .
Detection of ⌬⌿m and ROS Generation by Flow Cytometry. For measuring ⌬⌿m, CEM cells were stained with 20 nM tetramethylrhodamine methylester for 30 min at 37°C. The fluorescent intensities were measured in the FL3-H channel with a FACScan flow cytometer. The intracellular accumulation of ROS was determined using the fluorescent probe dihydroethidium to measure O 2 . (21) .
Bax Conformational Change. Cells were washed with PBS and lysed with Chaps buffer [10 mM HEPES (pH 7.4), 150 mM NaCl, 1% Chaps, 1 mM DTT, 0.1 mM phenylmethylsulfonyl fluoride, 3 g/ml aprotinin, 25 g/ml leupeptin, and 25 g/ml pepstain]. One g of anti-Bax (6A7) monoclonal antibody was preincubated with 20 l of Dynabeads (M-450 rat antimouse IgG1) at 4°C on the rotor for 3 h. The cell lysates were normalized for protein content, and 1000 g of total protein in 300 l Chaps lysis buffer were then added to the immuno-precipitation tube containing Bax antibody (6A7)-loaded Dynabeads and incubated at 4°C on the rotor overnight. After rinsing four times with Chaps buffer, beads were collected with a Dynal Magnetic Particle Concentrator (Dynal). Conformationally changed Bax protein was eluted with 25 l of sample buffer for Western blotting by the monoclonal anti-Bax antibody, clone 2D2 (22) .
Immunofluorescence Analysis of Cytochrome c Release. To colocalize cytochrome c in mitochondria, intact cells were first labeled with the mitochondrion-specific dye, MitoTracker red CMXRos. Cells in culture medium were incubated with MitoTracker (100 nM) at 37°C for 30 min. After washing, cells were fixed/permeabilized on slides. Cells were incubated with the anticytochrome c antibody 6H2.B4 (1:400 dilution) for 2 h and then incubated with FITC-conjugated antimouse secondary antibody (Sigma) at a 1:20 dilution. Slides were air dried at 4°C in the dark and stained with 4Ј,6-diamidino-2-phenylindole before being viewed under a Zeiss Axioskop fluorescence microscope (Carl Zeiss, Oberkochen, Germany; Ref. 23) .
Measurement of Cell Membrane Integrity by PI Dye Exclusion. After treatment, cells were stained with 10 g/ml PI for 5 min at room temperature. The PI fluorescence was measured by flow cytometry in the FL3-H channel. Intact cells were PI negative, and PI-positive cells were defined as necrotic cells with a broken cell membrane.
Measurement of Cytotoxicity by the MTT Test. MTT can be cleaved by mitochondrial enzymes, mainly by succinate dehydrogenase, to form a dark blue crystalline product, formazan. Reduced formation of formazan is caused by decreased mitochondrial dehydrogenase activity, inhibited cell proliferation, or cell death (14) . Cells (10 5 /ml) were treated for 24 h; MTT dye was added to each well to reach the final concentration of 50 g/ml and allowed to incubate for 4 h at 37°C. Plates were centrifuged and media replaced with 150 l of isopropyl alcohol containing 0.4 N HCl to solubilize the insoluble formazan complex. Absorbance at 540 nm was determined with an ELISA plate reader.
RESULTS
Bcl-2 Inhibitor, BH3I-2 or HA14-1, Sensitizes Leukemic CEM Cells to TRAIL-Induced Apoptosis. Human leukemic CEM cells are relevantly resistant to TRAIL-induced apoptosis because of a low level of caspase-8, induction of Bcl-2, and degradation of Bax protein (24) . We aimed to study whether switching on the mitochondrial apoptotic pathway could sensitize CEM cells to TRAIL-induced apoptosis. Measurement of apoptotic cells was performed by fixing cells, staining with PI, and analyzing by flow cytometry after treatment with 500 ng/ml of TRAIL. Apoptotic cells were defined as DNA content less than G 0 /G 1 (Fig. 1A) . The cell-permeable inhibitors for Bcl-2, BH3I-2Ј, and HA14-1 were used to test the synergistic effect on TRAIL-induced apoptosis. BH3I-2Ј did not significantly induce apoptosis at concentrations Ͻ50 M within 4 h. The concentration of BH3I-2Ј, which showed a significant synergistic effect on TRAILinduced apoptosis (t test, P Ͻ 0.001), started at 30 M (Fig. 1Ba) . Therefore, 30 M BH3I-2Ј were used to study the synergistic effect on TRAIL kinetically within 6 h, and it was shown (Fig. 1Bb ) that BH3I-2Ј significantly increased the sensitivity of CEM cells to TRAIL-induced apoptosis compared with cells treated with TRAIL . CEM cells were pretreated with 30 M BH3I-2Ј for 1 h and then treated with 500 ng/ml TRAIL for 6 h. Cells treated with TRAIL alone were used as control. Cells were collected at each indicated time point. C, synergistic effect of HA14-1 on TRAILinduced apoptosis. Dose-dependent course (a). CEM cells were pretreated with different doses of HA14-1 for 1 h and then incubated with (HϩT) or without (HA) 500 ng/ml TRAIL for 4 h. Timedependent course (b). CEM cells were pretreated with 10 M HA14-1 for 1 h and then treated with 500 ng/ml TRAIL for 6 h. Significantly increased sensitivity (‫ء‬P Ͻ 0.001) was statistically compared in cells that were treated with TRAIL and BH3I-2Ј or HA14-1 with those treated with TRAIL alone. D, colony formation assay. CEM cells in soft agar were treated with 30 M BH3I-2Ј or 10 M HA14-1 for 1 week. Cell numbers were counted in each grid. Data shown were mean Ϯ SD from three independent experiments. TRAIL, tumor necrosis factor-related apoptosis-inducing ligand.
alone (ANOVA, P Ͻ 0.001). The concentration of HA14-1, which showed a significant synergy (t test, P Ͻ 0.001) with TRAIL, started at about 6 M (Fig. 1Ca) . Ten M HA14-1 were used to assess the sensitization effect on TRAIL kinetically (Fig. 1Cb) , and again it showed a significant synergistic effect on TRAIL-induced apoptosis (ANOVA, P Ͻ 0.0001). The colony formation assay in soft agar was used to examine whether 30 M BH3I-2Ј or 10 M HA14-1 alone have an inhibitory effect on cell proliferation. It was observed that 30 M BH3I-2Ј or 10 M HA14-1 only slightly but not significantly inhibited colony formation (Fig. 1D) . These results imply that Bcl-2 inhibitors can sensitize TRAIL-induced apoptosis, and this sensitization is not a simple additive effect.
Bcl-2 Inhibitor Showed Similarities to the Classical Uncoupler CCCP. Previously we observed that BH3I-2Ј induces both cytochrome c release from mitochondria and reduction in ⌬⌿m at the concentration of 70 M, and these can be inhibited by Bcl-2/Bcl-XL (14) . In this study, we used 30 M BH3I-2Ј or 10 M HA14-1, which could not induce cytochrome c release nor apoptosis within 12 h (data not shown). We found that both BH3I-2Ј (30 M) and HA14-1 (10 M) induced a collapse in ⌬⌿m in the CEM cell line after treatment for 2 h ( Fig. 2A) was initially used as a positive control for the reduction of ⌬⌿m and the generation of ROS. Results indicated that Bcl-2 inhibitors showed some similar effects to the uncoupler CCCP on the MIM (i.e., the reduction of ⌬⌿m and the generation of ROS). It had been shown previously that the CEM cell line is relatively resistant to TRAILinduced reduction in ⌬⌿m (24) . When combined with BH3I-2Ј, HA14-1, or CCCP, TRAIL-mediated dissipation in ⌬⌿m was greatly enhanced ( Fig. 2A) . TRAIL alone did not induce production of ROS, and it did not show synergistic effect on BH3I-2Ј, HA14-1, or CCCPinduced generation of ROS (Fig. 2B) . We therefore investigated whether the uncoupler CCCP could sensitize CEM cells to TRAIL-induced apoptosis. The proapoptotic effect of CCCP on TRAIL was tested at both 4 and 24 h. CCCP did not induce apoptosis in CEM cells when used alone but showed a significant synergistic effect when it was combined with TRAIL. The percentages of apoptotic cells increased to 60 -70% when combined with CCCP compared with about 10 -20% apoptotic cell death when CEM cells were treated with TRAIL alone at 24 h (Fig. 2C) .
The synergistic effect of Bcl-2 inhibitors and CCCP on TRAILinduced apoptosis was also examined on other leukemic cell lines. Both HL-60 (Fig. 3A) and U937 (Fig. 3B ) cell lines were relatively resistant to TRAIL-induced apoptosis. However, TRAIL-induced apoptosis was significantly increased in both HL-60 and U937 cell lines when cells were pretreated with BH3I-2Ј, HA14-1, or CCCP (Fig. 3, A and B) . The K562 cell line is sensitive to TRAIL-induced apoptosis, as reported previously (19, 24) . Neither Bcl-2 inhibitors nor CCCP further sensitized K562 cells to TRAIL-induced apoptosis (Fig. 3C) .
To test whether these Bcl-2 inhibitors have an uncoupling effect on the mitochondria, mitochondrial respiration and ATP synthesis were examined. Mitochondrial respiration was measured by the oxygen consumption at the whole cell level. BH3I-2Ј and HA14-1 showed similar effect to CCCP in their ability to stimulate mitochondrial respiration rapidly (Fig. 4A) . ATP content was evaluated by luciferinluciferase after the treatment of cells for 4 h. As expected, BH3I-2Ј, HA14-1, and CCCP also inhibited ATP synthesis (Fig. 4B) . Treatment with TRAIL did not cause depletion of the intracellular ATP level but in contrast increased the ATP level. With the combination of TRAIL with BH3I-2Ј, HA14-1, or CCCP, ATP levels were further decreased when compared with those treated with these reagents alone (Fig. 4B) . This evidence suggests that the cell-permeable Bcl-2 inhibitors have a function in uncoupling mitochondrial respiration from oxidative phosphorylation.
Inhibitors of Bcl-2 but Not CCCP Induce Cytosolic Acidification. One of the functions of Bcl-2 is to maintain the physical H ϩ gradient across the MIM, and the proapoptotic protein Bax can cause cytosolic acidification and mitochondrial matrix alkalinization (25) . However, CCCP uncouples mitochondrial respiration by dissipating the H ϩ gradient across the MIM. We were therefore interested in whether there was a difference between Bcl-2 inhibitors and CCCP in the regulation of cytosolic pH value. Cells were stained with the pH-sensitive dye SNARF-1 acetate, and the change in the cytosolic pH value was measured by flow cytometry. A significant drop in pH value was observed when cells were treated with TRAIL, BH3I-2Ј, or HA14-1 alone for 4 h. However, CCCP did not cause pH change (Fig.  5) . This implies that the uncoupling and the acidification effects of Bcl-2 inhibitors are via a mechanism unrelated to the movement of protons across the MIM.
Uncoupling Effect Enhances TRAIL-Induced Bax Activation and Cytochrome c Release. To test whether the uncoupling effect that sensitized TRAIL-induced apoptosis was via the mitochondrial apoptotic pathway, Bax activation and cytochrome c release were examined in response to these treatments. Bax conformational change is a key step for the activation of Bax. Cellular proteins were extracted from treated cells and immuno-precipitated with an anti-Bax antibody, clone 6A7, which detects the active form of Bax specifically. TRAILinduced Bax activation was weakly detected after 4 h of treatment with TRAIL and was greatly enhanced by the cotreatment with BH3I-2Ј, HA14-1, or CCCP (Fig. 6) . The determination of cytochrome c release was performed by an immunostaining of triple colors. The mitochondria were stained as a red fluorescence, cytochrome c was stained as a green color, and the nuclei were stained with 4Ј,6-diamidino-2-phenylindole showing blue color (23) . Cytochrome c in control cells (Fig. 7A ) or cells treated with BH3I-2Ј (Fig.  7C) HA14-1 (Fig. 7E) or CCCP (Fig. 7G ) alone localized to mitochondria as red and green-merged pixels appeared orange/yellow. TRAIL-induced cytochrome c release was weakly shown in the CEM cells as the green-labeled cytochrome c image separating from the mitochondria with a clearly diffuse pattern (Fig. 7B) , and it was enhanced by cotreatment with BH3I-2Ј (Fig. 7D), HA14-1 (Fig. 7F) , or CCCP (Fig. 7H) .
Caspases Are Not Crucial for TRAIL-Induced Killing When Mitochondrial Respiration Is Uncoupled. Depletion of ATP may affect the apoptotic cell death because ATP is required for cytochrome c-dependent caspase activation (26) . We therefore tested whether caspase-3 activation was affected when the ATP level was low. Caspase-3 activity was measured by the fluorogenic assay using Z-DEVD-AFC as a substrate. Treatment with TRAIL alone for 4 h increased the activity of the caspase-3. BH3I-2Ј, HA14-1, or CCCPtreated cells did not show increased caspase-3 activity. However, when the TRAIL treatment was combined with BH3I-2Ј, HA14-1, or CCCP, all of these uncoupling agents showed a significant synergistic effect on TRAIL-induced activation of caspase-3 (Fig. 8A) regardless of the lower levels of ATP. This suggests that the synergistic effect of uncoupling agents on TRAIL-induced apoptosis is caspase dependent.
To evaluate the uncoupling effect on TRAIL-induced killing, a pan-caspase inhibitor, Z-VAD.fmk, was used to inhibit the activation of caspases. Z-VAD.fmk completely blocked the apoptotic cell death induced by TRAIL alone and cotreated with BH3I-2Ј, HA14-1, or CCCP after 4 h of treatment (data not shown). However, after 6 h of (Fig. 8B, a-c) , or TRAIL combined with BH3I-2Ј, HA14-1, or CCCP (Fig. 8B, d-f) , kept impermeable to PI, indicating the integrity of the cell membrane. However, cotreatment of cells with TRAIL and BH3I-2Ј, HA14-1, or CCCP in the presence of Z-VAD. fmk for 6 h, part of cells were permeable to PI, show the increased PI fluorescence in the FL3-H channel (Fig. 8B, g-i) . In addition, BH3I-2Ј, HA14-1, or CCCP alone did not induce necrosis in the presence of Z-VAD.fmk (data not shown). The MTT test confirmed that the inhibition of caspases failed to block the uncoupling effect-sensitized TRAIL-mediated killing (Fig. 8C) . Z-VAD.fmk could nor inhibit dissipation of ⌬⌿m or generation of ROS, which was induced by TRAIL when combined with BH3I-2Ј, HA14-1, or CCCP (data not shown), indicating that they induce permanent damage on the MIM. These results imply that the uncoupling effect facilitates TRAILinduced apoptosis when caspases are activated and leads to necrosis when caspases are inhibited.
DISCUSSION
In this study, we found that the inhibitors of Bcl-2, BH3I-2Ј, and HA14-1 can uncouple mitochondrial respiration at concentrations that could not induce cytochrome c release. Their function in dissipation of ⌬⌿m, generation of ROS, stimulation in oxygen consumption, and reduction in ATP synthesis were identical to the uncoupler CCCP. These uncoupling functions were associated with a marked synergy with TRAIL-induced apoptosis via the mitochondrial apoptotic pathway. They also induced necrotic cell death when caspases were inhibited. The synergistic effect of both Bcl-2 inhibitors and CCCP on TRAIL-induced apoptosis was detected in TRAIL-resistant leukemic cell lines, such as CEM, HL-60, and U937 but not in TRAILsensitive K562 cell line. This is in agreement with our previous study that TRAIL-induced apoptosis in the K562 cell line is via the mitochondria-independent pathway (7). This study showed evidence, for the first time, that the uncoupling effect can overcome resistance of leukemic cells to TRAIL-induced apoptosis.
The cell-permeable small nonpeptide compounds, BH3I-2Ј and HA14-1, are inhibitors for Bcl-2/Bcl-XL, or "BH3 mimetics," and function through their ability to occupy the hydrophobic pocket of Bcl-2/ Bcl-XL (12, 13) . It has been reported that BH3I-2Ј induces apoptosis by neither directly inducing Bax oligomerization and mitochondrial insertion nor by mediating pore formation by Bcl-XL (13). BH3I-2Ј and the other BH3Is induce apoptosis by inhibiting the heterodimerization of Bcl-2/ Bcl-XL and releasing the proapoptotic Bcl-2 family members, which in turn initiate downstream apoptotic events (13) . This presumed that "BH3 mimetic"-mediated apoptosis is indirectly achieved through activating Bax; however, Bax does not form channels on its own but interacts with and/or modulates a pre-existing mitochondrial outer membrane channel. Such a channel is termed the "permeability transition pore," which crosses both mitochondrial membranes at contacting sites and transports adenine nucleotides and other small molecules (27) . Both BH3I-2Ј and HA14-1 induced rapid reduction in ⌬⌿m and generation of ROS at concentrations that do not actively induce apoptosis. They have similarities to CCCP on the uncoupling function. In addition to the dissipation of ⌬⌿m and the generation of ROS, they uncouple ATP synthesis from mitochondrial respiration and increase the oxygen consumption. The only difference we observed between the Bcl-2 inhibitors and CCCP is that both BH3I-2Ј and HA14-1 induce cytosolic acidification, but CCCP does not. It has been reported that overexpression of Bax induces cytosolic acidification, which can be prevented by Bcl-2, and CCCP does not alter cytosolic pH value (25) . This may imply that the uncoupling effect of Bcl-2 inhibitors is not through dissipation of the H ϩ gradient across the MIM. The precise mechanism by which Bcl-2 inhibitors uncouple mitochondrial respiration is elusive. Bcl-2 protein has been identified in both MIM (28) and mitochondrial outer membrane (29) . Bcl-2 and Bcl-XL are proteins that maintain the integrity of both mitochondrial outer membrane and MIM (30) . The cell-permeable property of these Bcl-2 inhibitors may enable them to bind to Bcl-2/Bcl-XL in the MIM and disrupt their role as a gatekeeper of the MIM.
TRAIL did not show the ability to uncouple mitochondrial respiration because it could not inhibit ATP synthesis. The reduction in ⌬⌿m induced by TRAIL was caspase dependent. It has also been reported that neither tumor necrosis factor nor Fas uncouples mitochondrial respiration in the CEM cell line (16, 18) . The resistance of CEM cells to death receptor-mediated apoptosis may be largely associated with the lower expression of caspase-8 (18, 24, 31) . The requirement for a functional mitochondrial electron transport chain in TRAIL-induced apoptosis has not been widely investigated. Depletion of mitochondrial DNA rendered tumor cells resistant to TRAILinduced apoptosis (17) , and a deficiency in the mitochondrial electron transport chain, which confers resistance to TRAIL, is caused by reduction in both mitochondrial respiration and ATP synthesis. The uncoupling effect, which synergizes TRAIL-induced apoptosis, causes an increase in mitochondrial respiration and a decrease in ATP synthesis. These results imply that mitochondrial ATP synthesis is not crucial for the sensitivity of cells to TRAIL-induced apoptosis. We suggest that increased mitochondrial respiration and ROS generation may be responsible for the synergistic effect of the uncouplers to TRAIL-induced apoptosis. Cytochrome c-dependent activation of caspases requires ATP or dATP (26) , but the inhibition of ATP synthesis by either Bcl-2 inhibitors or CCCP did not abrogate TRAILinduced activation of caspase-3. This indicates that the residual levels of intracellular ATP are sufficient for the requirement of cytochrome c-induced caspase activation. However, following the inhibition of caspases, TRAIL induced necrosis in the presence of uncoupling agents. This suggests that caspases are not crucial for TRAIL-induced killing in the presence of uncoupler.
Despite the uncoupling effect, both Bcl-2 inhibitors and CCCP at the concentration used for this study did not induce Bax conformational change and cytochrome c release. However, they greatly sensitized TRAIL-induced Bax conformational change and cytochrome c release. It has been reported that Bax activation is associated with the loss of ⌬⌿m (32) or a rise in intracellular pH value (33) . Our results showed that either Bcl-2 inhibitors or CCCP alone did not induce Bax 5 . Effect of the uncouplers on cytosolic pH value. Cells were treated for 3 h and then were stained with SNARF-1. The pH value was calculated from a standard curve that was produced with every single experiment. Data shown are mean Ϯ SD from four independent experiments. Significant decreased pH value in treated cells (‫ء‬P Ͻ 0.001, t test) was compared with untreated control. E and F) , or CCCP (G and H) for 1 h and then incubated without TRAIL (A, C, E, G) or with TRAIL (B, D, F, H) for 3 h. Cells were then labeled with MitoTracker, fixed, permeabilized, stained with native anti-cytochrome c antibody, and finally counterstained with 4Ј,6-diamidino-2-phenylindole as described in "Materials and Methods." The stained cells were examined by fluorescence microscopy. Cytochrome c antibody was visualized with a fluorescent-conjugated antimouse IgG and assigned the color green, whereas mitochondria labeled with MitoTracker were assigned the color red. Nuclei were stained with 4Ј,6-diamidino-2-phenylindole and showed blue color. Cells that incubated with single agent show punctuated orange/yellow mitochondria (when red and green images were merged). Arrows show released cytochrome c (green), which was separate from mitochondria location (red). CCCP, carbonyl cyanide m-chlorophenylhydrazone; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand. 
